JP2005503394A5 - - Google Patents

Download PDF

Info

Publication number
JP2005503394A5
JP2005503394A5 JP2003523220A JP2003523220A JP2005503394A5 JP 2005503394 A5 JP2005503394 A5 JP 2005503394A5 JP 2003523220 A JP2003523220 A JP 2003523220A JP 2003523220 A JP2003523220 A JP 2003523220A JP 2005503394 A5 JP2005503394 A5 JP 2005503394A5
Authority
JP
Japan
Prior art keywords
rhinitis
disease
chronic
syndrome
asthma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003523220A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005503394A (ja
Filing date
Publication date
Priority claimed from GBGB0117899.5A external-priority patent/GB0117899D0/en
Application filed filed Critical
Publication of JP2005503394A publication Critical patent/JP2005503394A/ja
Publication of JP2005503394A5 publication Critical patent/JP2005503394A5/ja
Pending legal-status Critical Current

Links

JP2003523220A 2001-07-23 2002-07-19 ケモカインレセプター活性の調節剤として有用なピペリジン誘導体 Pending JP2005503394A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0117899.5A GB0117899D0 (en) 2001-07-23 2001-07-23 Chemical compounds
PCT/SE2002/001401 WO2003018556A1 (en) 2001-07-23 2002-07-19 Piperidine derivatives useful as modulators of chemokine receptor activity

Publications (2)

Publication Number Publication Date
JP2005503394A JP2005503394A (ja) 2005-02-03
JP2005503394A5 true JP2005503394A5 (enExample) 2006-01-12

Family

ID=9919003

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003523220A Pending JP2005503394A (ja) 2001-07-23 2002-07-19 ケモカインレセプター活性の調節剤として有用なピペリジン誘導体

Country Status (5)

Country Link
US (1) US7265227B2 (enExample)
EP (1) EP1412330A1 (enExample)
JP (1) JP2005503394A (enExample)
GB (1) GB0117899D0 (enExample)
WO (1) WO2003018556A1 (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR033517A1 (es) * 2000-04-08 2003-12-26 Astrazeneca Ab Derivados de piperidina, proceso para su preparacion y uso de estos derivados en la fabricacion de medicamentos
GB0013060D0 (en) * 2000-05-31 2000-07-19 Astrazeneca Ab Chemical compounds
GB0021670D0 (en) 2000-09-04 2000-10-18 Astrazeneca Ab Chemical compounds
SE0102809D0 (sv) * 2001-08-22 2001-08-22 Astrazeneca Ab Novel compounds
WO2003059965A1 (en) * 2002-01-10 2003-07-24 University Of Washington Hydrogels formed by non-covalent linkages
TW200303304A (en) * 2002-02-18 2003-09-01 Astrazeneca Ab Chemical compounds
SE0200843D0 (sv) * 2002-03-19 2002-03-19 Astrazeneca Ab Chemical compounds
SE0200844D0 (sv) * 2002-03-19 2002-03-19 Astrazeneca Ab Chemical compounds
SE0202838D0 (sv) * 2002-09-24 2002-09-24 Astrazeneca Ab Chemical compounds
BRPI0406761A (pt) 2003-01-14 2005-12-20 Arena Pharm Inc Derivados de arila e heteroarila 1,2,3-trissubstituìdos como moduladores do metabolismo e a profilaxia e tratamento de distúrbios relacionados a estes tais como diabetes e hiper-glicemia
SE0300850D0 (sv) * 2003-03-25 2003-03-25 Astrazeneca Ab Chemical compounds
SE0300957D0 (sv) * 2003-04-01 2003-04-01 Astrazeneca Ab Chemical compounds
EP1638939A2 (en) * 2003-06-24 2006-03-29 Neurosearch A/S Aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
SE0400208D0 (sv) * 2004-02-02 2004-02-02 Astrazeneca Ab Chemical compounds
SE0400925D0 (sv) * 2004-04-06 2004-04-06 Astrazeneca Ab Chemical compounds
US20060167044A1 (en) * 2004-12-20 2006-07-27 Arnaiz Damian O Piperidine derivatives and their use as anti-inflammatory agents
DOP2006000010A (es) * 2005-01-10 2006-07-31 Arena Pharm Inc Procedimiento para preparar eteres aromáticos
WO2006126948A1 (en) * 2005-05-27 2006-11-30 Astrazeneca Ab Piperidines for the treatment of chemokine mediated diseases
TW200722419A (en) * 2005-05-27 2007-06-16 Astrazeneca Ab Chemical compounds
AU2006264043B2 (en) 2005-06-28 2012-04-26 Sanofi-Aventis Isoquinoline derivatives as inhibitors of Rho-kinase
KR20080037655A (ko) * 2005-07-21 2008-04-30 아스트라제네카 아베 신규 피페리딘 유도체
CN101228132B (zh) 2005-07-26 2012-10-10 塞诺菲-安万特股份有限公司 作为Rho-激酶抑制剂的环己基胺异喹啉酮衍生物
CN101228149B (zh) 2005-07-26 2013-01-02 塞诺菲-安万特股份有限公司 作为Rho-激酶抑制剂的哌啶基取代的异喹啉酮衍生物
TW200812582A (en) * 2006-04-06 2008-03-16 Astrazeneca Ab Medicaments
NZ577981A (en) 2006-12-27 2011-12-22 Sanofi Aventis Substituted isoquinoline and isoquinolinone derivatives as inhibitors of rho-kinase
RU2457203C2 (ru) 2006-12-27 2012-07-27 Санофи-Авентис Замещенные циклоалкиламином производные изохинолона
BRPI0720909A2 (pt) 2006-12-27 2016-11-01 Sanofi Aventis derivados de isoquinolina e isoquinolinona substituídos
AU2007338412B2 (en) 2006-12-27 2013-03-14 Sanofi-Aventis Cycloalkylamine substituted isoquinoline and isoquinolinone derivatives
MX2009006517A (es) 2006-12-27 2009-06-26 Sanofi Aventis Nuevos derivados de isoquinolina e isoquinolinona sustituidos.
EP2125746B1 (en) 2006-12-27 2012-04-18 Sanofi Cycloalkylamine substituted isoquinoline derivatives
MY157330A (en) 2008-06-24 2016-05-31 Sanofi Aventis Substituted isoquinolinones as rho kinase inhibitors
AU2009262509B2 (en) 2008-06-24 2014-01-30 Sanofi Bi-and polycyclic substituted isoquinoline and isoquinoline derivatives as Rho kinase inhibitors
KR101607090B1 (ko) 2008-06-24 2016-03-29 사노피 6-치환된 이소퀴놀린 및 이소퀴놀리논
SG188548A1 (en) 2010-09-22 2013-04-30 Arena Pharm Inc Modulators of the gpr119 receptor and the treatment of disorders related thereto
AU2016205361C1 (en) 2015-01-06 2021-04-08 Arena Pharmaceuticals, Inc. Methods of treating conditions related to the S1P1 receptor
CA3002551A1 (en) 2015-06-22 2016-12-29 Arena Pharmaceuticals, Inc. Crystalline l-arginine salt of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta[b]indol-3-yl)acetic acid(com pound 1)for use in s1p1 receptor-associated disorders
CA3053418A1 (en) 2017-02-16 2018-08-23 Arena Pharmaceuticals, Inc. Compounds and methods for treatment of primary biliary cholangitis
CA3102136A1 (en) 2018-06-06 2019-12-12 Arena Pharmaceuticals, Inc. Methods of treating conditions related to the s1p1 receptor

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1243991A (en) 1968-06-10 1971-08-25 Ici Ltd Piperidine, morpholine and piperazine derivatives
US4335127A (en) * 1979-01-08 1982-06-15 Janssen Pharmaceutica, N.V. Piperidinylalkyl quinazoline compounds, composition and method of use
DK159420C (da) 1983-03-09 1991-03-11 Ciba Geigy Ag N-(piperidinyl-alkyl)-carboxamider og salte deraf, farmaceutiske praeparater indeholdende disse forbindelser samt anvendelsen af forbindelserne til fremstilling af antipsykotiske farmaceutiske praeparater
FI853477A7 (fi) * 1984-09-14 1986-03-15 Ciba Geigy Ag Menetelmä karbonyyliyhdisteiden valmistamiseksi.
CA1246074A (en) 1984-12-05 1988-12-06 Albertus H.M.T. Van Heertum Derivatives of hydroxy- or amino-substituted (piperidinylalkyl)quinazolines
KR910006138B1 (ko) 1986-09-30 1991-08-16 에자이 가부시끼가이샤 환상아민 유도체
EP0429341A3 (en) 1989-11-20 1991-11-13 Rhone-Poulenc Sante Heterocyclic derivatives, their preparation and pharmaceuticals containing them
JP2860689B2 (ja) 1990-03-14 1999-02-24 第一製薬株式会社 ピリミジン誘導体
FR2667317B1 (fr) * 1990-10-02 1992-12-04 Synthelabo Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.
RU1824396C (ru) * 1991-02-28 1993-06-30 Харьковский фармацевтический институт Пиперидиламид 3,5-дибром-4-аминобензолсульфонилсукцинаминовой кислоты, про вл ющий нейролептическое и мочегонное действие
FR2675801A1 (fr) 1991-04-24 1992-10-30 Rhone Poulenc Rorer Sa Piperidines, leur preparation et les medicaments les contenant.
US5143923B1 (en) * 1991-04-29 1993-11-02 Hoechst-Roussel Pharmaceuticals Incorporated Benzoisothiazole-and benzisoxazole-3-carboxamides
FR2676054B1 (fr) * 1991-05-03 1993-09-03 Sanofi Elf Nouveaux composes n-alkylenepiperidino et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
EP0661266A1 (en) * 1993-12-27 1995-07-05 Toa Eiyo Ltd. Substituted cyclic amine compounds as 5HT2 antagonists
FR2724382B1 (fr) 1994-09-13 1996-10-18 Synthelabo Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique
ES2087038B1 (es) 1994-11-07 1997-03-16 Uriach & Cia Sa J Nuevas piperidinas con actividad antagonista del paf.
WO1996029330A1 (en) 1995-03-22 1996-09-26 Taisho Pharmaceutical Co., Ltd. Thiazole derivatives
JPH0940646A (ja) 1995-07-27 1997-02-10 Yamanouchi Pharmaceut Co Ltd ベンゼン縮合環誘導体又はその塩
JPH0977742A (ja) 1995-09-12 1997-03-25 Kyorin Pharmaceut Co Ltd 新規なベンズアミド誘導体
AU727972B2 (en) 1996-05-16 2001-01-04 H. Lundbeck A/S Dihydropyrimidines and uses thereof
EP0912505A4 (en) 1996-06-27 2001-10-24 Smithkline Beecham Corp IL-8 RECEPTOR ANTAGONISTS
US6323206B1 (en) 1996-07-12 2001-11-27 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
AU8576098A (en) 1997-07-25 1999-02-16 Merck & Co., Inc. Cyclic amine modulators of chemokine receptor activity
IL125658A0 (en) 1997-08-18 1999-04-11 Hoffmann La Roche Ccr-3 receptor antagonists
EP1047675A1 (en) 1998-01-21 2000-11-02 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
JP2002501898A (ja) 1998-02-02 2002-01-22 メルク エンド カムパニー インコーポレーテッド ケモカイン受容体活性の環状アミン調節剤
PT1131291E (pt) 1998-11-17 2005-01-31 Hoffmann La Roche Antagonistas iii do receptor 4-aroil-piperidin-ccr-3
US6331545B1 (en) 1998-12-18 2001-12-18 Soo S. Ko Heterocycyclic piperidines as modulators of chemokine receptor activity
CZ20013451A3 (cs) 1999-03-26 2002-04-17 Astrazeneca Ab Nové sloučeniny
SE9902987D0 (sv) 1999-08-24 1999-08-24 Astra Pharma Prod Novel compounds
GB0013060D0 (en) * 2000-05-31 2000-07-19 Astrazeneca Ab Chemical compounds
GB0021670D0 (en) 2000-09-04 2000-10-18 Astrazeneca Ab Chemical compounds
WO2002022572A2 (en) 2000-09-11 2002-03-21 Sepracor, Inc. Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission)
AU2002215928A1 (en) 2000-10-09 2002-04-22 Novartis Pharma Gmbh N-(4-aryloxypiperidin-1-ylalkyl) cinnamic amides as ccr3 receptor antagonists
SE0102809D0 (sv) 2001-08-22 2001-08-22 Astrazeneca Ab Novel compounds

Similar Documents

Publication Publication Date Title
JP2005503394A5 (enExample)
JP2003507456A5 (enExample)
JP2009506123A5 (enExample)
JP2004520423A5 (enExample)
JP2009507792A5 (enExample)
JP2005521675A (ja) 喘息、ｃｏｐｄおよび他の疾患の治療におけるインドール−３−酢酸の使用
US20050101612A1 (en) Use of indole-3-acetic acids in the treatment of asthma, copd and other diseases
DE69937405T2 (de) Stickstoffheterocyclische Carboxamidverbindungen oder deren Salze als antivirale Mittel
DE69628334T2 (de) Chinolin derivate als nk3 antagoniste
JP2009528991A5 (enExample)
ES2309539T3 (es) Compuestos de sulfonamida que modulan la actividad de los receptores de la quimioquina (ccr4).
JP2011063620A (ja) ピペリジンおよびピペラジン誘導体
EP1740532A2 (en) Hydrazide-containing cftr inhibitor compounds and uses thereof
WO2007053197A3 (en) Nanoparticulate acetaminophen formulations
EP1893212A2 (en) Multicyclic compounds and methods of their use
JP2009532417A5 (enExample)
JP2011518207A (ja) 殺真菌剤ヒドロキシモイル−ヘテロ環誘導体
JP2010520893A5 (enExample)
CA2403423A1 (en) Tri-aryl-substituted-ethane pde4 inhibitors
JP2017520571A5 (enExample)
CN114450275A (zh) 杂芳基氨基吡啶醇衍生物以及包含其为活性成分的用于预防或治疗自身免疫性疾病的药物组合物
ES2314445T3 (es) Nuevas n-pirazinil-fulfonamidas condensadas y su uso en el tratamiento de enfermedades mediadas por quimioquinas.
UA80888C2 (en) Imidazole derivatives as glutmate receptor antagonists
JP2004524359A (ja) ケモカインレセプターのモジュレーターとしての新規ピペリジン誘導体
NZ547523A (en) Novel tiotropium salts, methods for the production thereof, and pharmaceutical formulations containing the same